GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Slc23a2 | decreases expression | EXP | | 6480464 | CTD | Ascorbic Acid results in decreased expression of SLC23A2 mRNA | PMID:19418264 | Slc23a2 | increases abundance | ISO | Slc23a2 (Mus musculus) | 6480464 | CTD | SLC23A2 mRNA results in increased abundance of Ascorbic Acid | PMID:22558179 | Slc23a2 | increases expression | ISO | Slc23a2 (Mus musculus) | 6480464 | CTD | Ascorbic Acid deficiency results in increased expression of SLC23A2 protein; Ascorbic Acid results in increased expression of SLC23A2 mRNA | PMID:20122894 PMID:22001929 | Slc23a2 | multiple interactions | ISO | SLC23A2 (Homo sapiens) | 6480464 | CTD | Ascorbic Acid inhibits the reaction [nickel sulfate results in decreased expression of SLC23A2 mRNA]; Diclofenac inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid]; Estradiol inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid]; Genistein inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid]; Hydrocortisone inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid]; Indomethacin inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid]; Progesterone inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid]; Quercetin inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid] | PMID:16288478 PMID:17092984 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |